Less noise. More signal.
01
Every board in life sciences is asked the same question. Who manufactures the future for the AI outcome. The role most boards will appoint does not yet exist at scale.
02
The white space is the room that holds manufacturing decisions differently. Closed-door. By invitation. Before the queue forms. A circle for the leaders building what comes next.
03
the Annual. AIO is that room. Senior leadership preparing for AI accountability convened across drug discovery, R&D, manufacturing and supply. Less noise. More signal.
04
In the Annual. Faculty drawn from the leaders already carrying the responsibility · with or without the title. Announced in cadence with the programme.
The role that does not yet exist at scale.
The gap.
Biology moves faster than infrastructure. Leaders know they must scale · few yet have the process. Facilities without governance · stall. Pilots without scale · break. The line between drug candidate and clinical supply is the decision that holds both.
the Circle.
BILS convenes the leaders preparing for that role · across drug discovery, R&D, manufacturing and supply. The corridor where AI ambition becomes clinical outcome · or breaks. the Circle closes the gap.
The decision.
What scales. What purifies. Who manufactures the future. Three questions the room must hold before the queue forms. For the leaders shaping what comes next.
"the Circle within the Annual. Where the role is shaped before it is named."
Uwe Gottschalk · Former CSO Lonza · Operating Partner, Keensight Capital
By invitation. By relevance. By room.
Attend BILS 2027